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in rabies pathogenesis are shown in Figure 1 . During most of the incubation period, usually lasting weeks or months, the virus is probably located close to the site of entry. Rabies virus binds to the nictotinic acetylcholine receptor at the neuromuscular junction. 1 The virus spreads towards the central nervous system (CNS) in the axons of peripheral nerves by retrograde fast axonal transport (about 250 mm/day). 2 In the CNS the virus is also transported within axons by fast axonal transport along neuroanatomical connections 3 and quickly becomes disseminated throughout the CNS. Subsequently, the virus travels centrifugally along autonomic and sensory pathways to multiple organs, including the salivary glands, heart, adrenal medulla, and skin. 4 This is important for the development of salivary gland infection in rabies vectors and also for human diagnosis using skin biopsies. 5, 6 There may be infection of cardiac ganglia and the myocardium 4 and, in some cases, there is a myocarditis. [7] [8] [9] In rabies there are mild inflammatory changes in the CNS. Neurons are the neural cell type predominantly infected by rabies virus and there are few degenerative changes in neurons. Infected neurons may contain eosinophilic inclusions in the cytoplasm called Negri bodies ( Figure 2 ). Negri bodies are most prominent in large neurons (e.g., Purkinje cells) and, ultrastructurally, they are composed of large aggregates of granulo-filamentous matrix material and variable numbers of viral particles.
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EPIDEMIOLOGY
Rabies remains an important public health problem in resource-limited and resource-poor countries, particularly in Asia and Africa. This situation occurs because dog rabies is endemic with dog-to-dog transmission of the infection, which is associated with an ongoing threat to humans due to dog bites. Unfortunately, children share a disproportionately high burden of the disease. There are probably about 75,000 human deaths per year worldwide from rabies. In North America wildlife rabies is present in bats and in a number of terrestrial species, including skunks, raccoons, and foxes 13 ( Figure 3 ). Most indigenously acquired human cases in North America are caused by rabies virus variants associated with insectivorous bats. Most important for causing human rabies is a variant isolated from silver-haired (Lasionycteris noctivagans) and eastern pipistrelle (Pipistrellus subflavus) bats, which are small bats and may explain the failure to recognize bites from these species. Less commonly, human rabies may be due to a variant from Brazilian THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES 690 (also called Mexican) free-tail bats (Tadarida braziliensis) and also to variants associated with other bat species. Bat bites may appear trivial and not be recognized (Figure 4 ) or there may even be no known exposure to bats. The majority (60%) of human cases of rabies due to bat variants in the United States and Canada do not give a history of a bat bite or scratch and 33% have no history of contact with bats at all. 14 Hence, the absence of a history of an animal bite or even the absence of a history of contact with bats is common in association with human rabies cases. Of the last seven human cases of rabies that have occurred in Canada since 1970, all except one (6/7 or 86%) were transmitted by insectivorous bats (Table 1) . (Table 2 ) . In addition, there are eight well-documented cases of rabies transmitted by corneal transplantation 30 and there also were three cases associated with corneal transplantation from donors with rabies in which the recipients did not develop rabies. 31, 32 Clinical screening of organ and tissue donors is important, but laboratory screening for rabies is problematic because of time limitations, a variety of logistical issues, and difficulties associated with false positive results, which would lead to wastage of valuable organs in a situation in which there is already a serious shortage of available organs for transplantation.
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CLINICAL FEATURES
The incubation period from the time of the exposure until the onset of clinical disease is usually 20 to 90 days, but the period may last for only a few days or exceed a year. The earliest clinical features in the prodromal period are usually non-specific and include fever, malaise, fatigue, anorexia, headache, and anxiety. During this period patients may experience pain, paresthesias, and pruritus at the site of bite, and the wound has often healed by this time. These symptoms are likely due to infection and inflammatory changes in local sensory ganglia (dorsal root or cranial ganglia). There are two clinical forms of rabies: an encephalitic form in 80% and a paralytic form in 20%. The bases for the two different forms are not clearly understood, but there is likely greater burden of disease in paralytic rabies involving the spinal cord, spinal nerve roots, and peripheral nerves, whereas in encephalitic rabies the burden of disease is greater in the brain. In encephalitic rabies there are often episodes of generalized arousal or hyperexcitability separated by lucid intervals. 33 Autonomic dysfunction is common and includes hypersalivation, piloerection (gooseflesh), cardiac arrhythmias, and priapism. The most characteristic feature is hydrophobia, which involves spasms of the diaphragm and other inspiratory muscles (lasting 5-15 seconds) on attempts to swallow. This is reinforced by conditioning and the sight of liquids may precipitate spasms. A draft of air can also produce spasms (aerophobia). The disease progresses with development of stupor and coma, quadriparesis, and organ failure, which requires management in a critical care setting.
Paralytic rabies usually begins with paresis in the bitten extremity with spread to quadriparesis and bilateral facial weakness. Sphincters are often affected and there is usually minimal sensory involvement. Hydrophobia does not normally develop in paralytic rabies. There is progression of paralytic rabies to coma and organ failure, typically with a longer clinical course than in encephalitic rabies.
MEDICAL COMPLICATIONS
Cardiac disorders are common medical complications of rabies, which may occur in a critical care unit. Sinus tachycardia is very common and the heart rate is often greater than would be expected for the degree of fever. 34 Heart failure, hypotension, and cardiac arrest may occur as well as a variety of cardiac arrhythmias, including wandering atrial/nodal pacemaker, sinus bradycardia, and supraventricular or ventricular ectopic beats/arrhythmias. 34, 35 The cardiac manifestations probably reflect infection involving the autonomic nervous system (e.g., cardiac ganglia) or myocardium. 4 There may be an associated myocarditis. [7] [8] [9] Respiratory complications include hyperventilation, hypoxemia, respiratory depression with apnea, atelectasis, and aspiration pneumonia. 35 Either hyperthermia or hypothermia may be present, which may reflect hypothalamic involvement in the infection. Gastrointestinal hemorrhage is a common complication. 36 Endocrine complications include inappropriate secretion of antidiuretic hormone and diabetes insipidus. 35, 37 
BRAIN DEATH AND RABIES
A Canadian case of rabies has illustrated that patients with rabies may remain for a prolonged period in a brain death-like state; survival has never been reported in this setting. In Edmonton a patient with rabies was maintained in a therapeutic coma from 15 to 42 days after symptom onset, and he remained comatose for over three weeks after the sedation was discontinued. 24 On Day 43 an electroencephalogram was "near isoelectric." On Day 64 a neurologic examination and apnea testing were consistent with brain death, and a nuclear medicine perfusion scan showed "preservation of cerebral blood flow." 24 Supportive care was withdrawn and he died on Day 65; autopsy showed "complete neuronal loss" in the cerebral cortex 24 and also extensive neuronal loss in the brainstem (Dr. Christopher Power, personal communication). This case illustrates that rabies is a disorder in which brain blood flow may be preserved in association with brain death.
THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
LABORATORY INVESTIGATIONS
A clinical suspicion of rabies is necessary in order to initiate the appropriate diagnostic laboratory tests for rabies. Routine blood work is generally not helpful. Computed tomogram (CT) imaging of the brain is only useful to exclude other diseases. Magnetic resonance imaging (MRI) of the brain may be normal or may show lesions in gray matter areas of the brain parenchyma, including the brainstem. [38] [39] [40] [41] Cerebrospinal fluid (CSF) analysis often shows a mild mononuclear pleocytosis (less than 100 leukocytes per μL). Positive rabies serology with the demonstration of serum neutralizing anti-rabies virus antibodies is diagnostic of rabies in a previously unimmunized individual, but may not become positive until a week or more after the onset of clinical illness. The presence of CSF neutralizing anti-rabies virus antibodies is considered diagnostic of rabies encephalitis. Rabies virus isolation is unusual except from brain tissues obtained by a diagnostic biopsy or post-mortem. Detection of rabies virus antigen or RNA in tissues or fluids is the usual method of making a laboratory diagnosis. A full thickness punch skin biopsy (usually 5 -6 mm in diameter) containing hair follicles (minimum of ten) can be obtained from the posterior region of the neck at the hairline. Multiple sections should be prepared of the biopsy specimen with immunostaining for rabies virus antigen, which is usually performed using the direct fluorescent antibody technique. 5, 6 The skin biopsy specimen can also be analyzed for rabies virus RNA using reverse transcription polymerase chain reaction (RT -PCR) amplification. 42 Further analysis, including sequencing, will allow specific identification of the rabies virus variant. Saliva specimens (collected with a sterile eyedropper pipette) can also be evaluated for rabies virus RNA using RT -PCR and these specimens have high sensitivity, whereas detection of rabies virus RNA using RT -PCR on CSF is less sensitive. Corneal impression smears have relatively low sensitivity for detection of rabies virus antigen. Negative laboratory tests, unless performed on brain tissues, do not exclude rabies, and further specimens may need to be obtained at a later time in the course of disease.
MANAGEMENT OF RABIES
Apart from the situation with organ and tissue transplantation, there is only a single report from Ethiopia indicating two cases with presumed human-to-human transmission of rabies. 43 There have been no reports of transmission to health care workers, but this remains a significant and important theoretical concern. Hence, barrier techniques should be initiated as soon a diagnosis of rabies is suspected in order to prevent exposures of health care workers and family members, particularly in a critical care unit setting. Oral secretions are of particular concern because of the possibility that they may contain infectious rabies virus and result in transmission to family members or health care workers.
Rabies is almost invariably fatal, but there are situations in which a decision may be made to embark on aggressive approach to therapy that will require the full resources of a critical care unit and be associated with a high risk of failure. Most survivors of rabies have received doses of rabies vaccine prior to the onset of their clinical illness. 30 The following should be considered a "favorable" factors for initiating an aggressive therapeutic approach: 1) therapy with dose(s) of rabies vaccine prior to the onset of illness, 2) young age, 3) healthy and immunocompetent individual, 4) rabies caused by a bat rabies variant (e.g., in contrast to a canine variant), 5) early presence of neutralizing anti-rabies virus antibodies in serum and CSF, and 6) mild neurological disease at the time of initiation of therapy. For example, an elderly immunosuppressed individual with advanced clinical disease (e.g., in coma) due to rabies would be a poor candidate for an aggressive approach. Laboratory tests for the detection of rabies virus antigen and RNA may be persistently negative in potential rabies survivors because viral clearance has already been initiated by the individual's immune response. A number of therapeutic options have been outlined in a viewpoint article by experts in clinical aspects of rabies and in basic rabies research. 44 Therapy with a combination of agents was felt to be a more promising approach than using a single agent, and this approach has proved to be successful in diseases such as cancer and in other infectious diseases, including human immunodeficiency virus infection and chronic hepatitis C virus infection. Specific agents discussed for therapeutic consideration include rabies vaccine, human rabies immune globulin, ribavirin, interferon-α, and ketamine. The inclusion of ketamine was based on in vitro and rat model studies performed at Institut Pasteur in Paris in the early 1990s. 45 More recent in vitro and mouse model studies now cast doubt on the efficacy of ketamine therapy 46 and further studies are needed to determine whether there is significant efficacy of therapy with ketamine in an animal model of rabies before ketamine becomes a routine therapy for human patients with rabies.
In 2004 a 15-year-old female was bitten by a bat and about a month later she developed clinical rabies. 47 She did not receive post-exposure rabies prophylaxis, including rabies vaccine. On presentation she had detectable neutralizing anti-rabies virus antibodies in her serum and CSF and all laboratory tests were negative for the detection of rabies virus antigen and RNA. She was treated with a therapeutic (induced) coma consisting of intravenous midazolam and supplemental phenobarbital to maintain a burst -suppression pattern on her electroencephalogram. She was also given antiviral therapy with ribavirin and also amantadine. Amantadine therapy was justified on the basis of an obscure in vitro report, 48 although the risk of adverse effects would be expected to be very low with this therapy. Ketamine was given as a continuous intravenous infusion at a dosage of 48 mg/kg/day. The patient survived with only mild persisting neurological deficits. 49 This therapeutic success has been followed by at least 20 documented failures to reproduce this therapeutic approach, dubbed the "Milwaukee Protocol," which has been relentlessly promoted (Table 3) . [37] [38] [39] Therapeutic coma for rabies or any other infectious disease has no clear scientific rationale and this therapy may only subject patients with rabies to a risk of developing adverse effects. Most concerning is the presence of abundant evidence of rabies virus antigen 24 and/or high copies numbers of rabies virus RNA 29 in the post-mortem brains of therapeutic failures, including one patient who had complete loss of neurons in the cerebral cortex at autopsy 24 and extensive loss of brainstem neurons (Dr. Christopher Power, personal communication). These reports provide abundant evidence that the therapy has failed to produce clearance of rabies virus from the brain. New approaches to the therapy of human rabies are needed rather than repeating this flawed therapy.
CONCLUSIONS
Rabies continues to be an international public health problem. The diagnosis of rabies needs to be considered even in the absence of a known animal exposure. Appropriate diagnostic laboratory testing should be performed in order to confirm a diagnosis of rabies, including rabies serology and testing of specimens, including saliva and skin biopsies, for the detection of rabies virus antigen and RNA. There is no known effective therapy for rabies and new approaches need to be developed in light of repeated failures of the Milwaukee Protocol.
